Explority AI

Problem: Pharma companies lose $185 billion each year on failed drugs, with only 2.5% of early-stage therapies succeeding in trials.

Solution: We've matched 1M+ research papers with real trial outcomes, training LLMs to predict – from research landscapes – which early-stage therapies will succeed, with top-ranked assets showing 4× higher success rates than the industry average.

Product: We’re bringing this technology as a B2B SaaS to pharma BizDev, VC and R&D teams, helping life-saving therapies reach millions of patients faster and with a better ROI. Our current focus – rare diseases.